Bepra 20 mg 14 tablets

Tradename

Bepra

Bepra

Composition

Each tablet contains:

Rabeprazole sodium 20 mg

Auxiliary components:

Mannitol, calcium hydroxide, hypromellose, talc, titanium dioxide, ethanol, acetone, purified water.

Properties

Antiulcer agent, inhibitor of H + -K + -ATPase (proton pump). The mechanism of action is associated with inhibition of the enzyme H + K + -ATPase in the parietal cells of the stomach, which leads to blocking the final stage of the formation of hydrochloric acid. This action is dose-dependent and leads to inhibition of both basal and stimulated secretion of hydrochloric acid, regardless of the nature of the stimulus.

Indications

Peptic ulcer of the stomach and duodenum the acute phase; peptic ulcer of the stomac and duodenum associated with Helicobacter pylori (in combination with antibiotics); gastroesophageal reflux.

Method of administration and dosage:

The optimal dosage regimen is determined by the doctor. It is necessary to strictly observe the compliance of the used dosage form of a particular drug with the indications for use and the dosage regimen.

Contraindications

Pregnancy, lactation (breastfeeding), hypersensitivity to sodium rabeprazole or substituted benzimidazoles.

Precautions:

Before starting therapy, it is necessary to exclude malignant neoplasms of the stomach, because the use of rabeprazole can mask symptoms and delay correct diagnosis.

Side effects

From the digestive system: diarrhea, nausea, abdominal pain, vomiting, flatulence, constipation; rarely — dry mouth, dyspepsia, belching; in isolated cases — anorexia, gastritis, stomatitis, increased activity of hepatic transaminases.

From the side of the central nervous system and peripheral nervous system: headache, asthenia, dizziness, insomnia; rarely nervousness, drowsiness; in isolated cases depression, impaired vision and taste.

From the respiratory system: possible — rhinitis, pharyngitis, cough; rarely — sinusitis, bronchitis.